Search This Blog

Saturday, March 29, 2025

AstraZeneca's Imfinzi gains additional indication for bladder cancer

FDA approves new use for AstraZeneca's Imfinzi in muscle invasive bladder cancer.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.